Breast cancer histology and hormonal status characterization in Libyan patients; a sample from middle region
DOI:
https://doi.org/10.37375/sjms.v1i2.320Keywords:
Breast carcinoma, invasive ductal carcinoma, hormonal statusAbstract
Background: Breast cancer, has increased in developed and developing countries among females, and in Libya, often diagnosed at advanced stage. This study conducted to evaluate histological features and hormonal status of breast carcinoma in Libyan females.
Materials and Methods: This retrospective study was performed at Sirte Oncology Centre, Sirte, Libya. Demographic characteristics, such as age, sex, marital status recorded. Histopathology examination provided the histologic type, grade, tumor size, stage, lymph node status, site of metastasis and hormonal status. Data were obtained and analyzed using SPSS software version18.0.
Results: A total of 74 breast cancer patients of which 72 (97.3%) were females and 2 (2.7%) were males. Majority of the cases occurred in the 5th decades. Invasive ductal carcinoma of no specific type was the most commonly diagnosed type of breast carcinoma accounting 95.9% of total cases, invasive lobular, ductal and lobular carcinoma and malignant phylloides were the second most common types. Majority of cases (57.4%) diagnosed with grade III tumors and 60 % of cases were found at advanced invasive and metastatic stage of breast cancer. Most of cases showed positive hormonal receptors (both ER and PR positive) (67.2%) while triple negative (ER, PR, and Her2Neu negative) cases were found to be the rarest group (1.6%).
Conclusion: Invasive ductal carcinoma was the most common histological type of breast cancer in Libyan patients, commonly diagnosed with a higher grade and at advanced stage. As hormonal status carries a hope of benefit from hormonal treatment, so our study places the significance of early detection, histo-pathological informations and hormonal status in an appropriate treatment strategy.
References
Anon. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries - Sung - 2021 - CA: A Cancer Journal for Clinicians - Wiley Online Library. Available at: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21660.
Elzouki I, Benyasaad T, Altrjoman F, et al. Cancer incidence in western region of Libya: Report of the year 2009 from tripoli pathology-based cancer registry. Libyan Journal of Medical Sciences 2018;2:45.
Elzouki A-N, Alkhomsi S. Pattern of gastrointestinal tract cancer in the Eastern part of Libya. Garyounis Med J 2005;22:27-31.
El Mistiri M, El-Mangush M, El-Sahli N, et al. Cancer incidence in Eastern Libya: preliminary result of the year 2003. La Tunisie médicale 2006;83 Suppl 12:18-9.
Anon. Cancer profile in Eastern Libya: incidence and mortality in the year 2004 - Annals of Oncology. Available at: https://www.annalsofoncology.org/article/S0923-7534(19)40073-2/fulltext.
Elzouki A-NY, Buhjab SI, Alkialani A, et al. Gastric cancer and Helicobacter pylori infection in the eastern Libya: a descriptive epidemiological study. Arab J Gastroenterol 2012;13:85-88.
Benyasaad T, Altrjoman F, Enattah N, et al. Cancer incidence in Western Libya: First results from Tripoli medical center. Ibnosina Journal of Medicine and Biomedical Sciences 2017;9:37. Available at: http://www.ijmbs.org/article.asp?issn=1947-489X;year=2017;volume=9;issue=2;spage=37;epage=45;aulast=Benyasaad;type=0.
Dupont WD, Page DL. Risk Factors for Breast Cancer in Women with Proliferative Breast Disease. New England Journal of Medicine 1985;312:146-151. Available at: https://doi.org/10.1056/NEJM198501173120303.
Anon. Breast cancer. Available at: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
Anon. National cancer control programmes : policies and managerial guidelines. Available at: https://apps.who.int/iris/handle/10665/42494.
Ermiah E, Abdalla F, Buhmeida A, et al. Diagnosis delay in Libyan female breast cancer. BMC Res Notes 2012;5:452.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 2002.
Eman Gusbi EG, Elzagheid A, Enattah N, et al. Breast Cancer in Western Part of Libya: Pattern and Management (2003-2018). Libyan Journal of Medical Sciences 2020;4.
Boder JME, Elmabrouk Abdalla FB, Elfageih MA, et al. Breast cancer patients in Libya: Comparison with European and central African patients. Oncol Lett 2011;2:323-330.
Bodalal Z, Khaial F, Elramli A, et al. A Study of Risk Factors for Breast Cancer in a Primary Oncology Clinic in Benghazi-Libya. International Journal of Statistics in Medical Research 2015;4:156-160.
Elhabbash MM, Alwindi AM. Breast cancer in Tripoli/Libya: 1990-2008. JCO 2010;28:e12052-e12052.
Zeeneldin AA, Ramadan M, Elmashad N, et al. Breast cancer laterality among Egyptian patients and its association with treatments and survival. Journal of the Egyptian National Cancer Institute 2013;25:199-207.
Wang L, Yang G, Chen J, et al. A clinical database of breast cancer patients reveals distinctive clinico-pathological characteristics: a study from central China. Asian Pacific journal of cancer prevention : APJCP 2014; 15:1621-6.
Reddy R, Chaitanya B, Latha P. Histopathological Prognostic Factors In Carcinoma Breast - An Indian Institutional Experience. Int J Med R es Rev 2014;2:573-7.
Siddiqui M, Kayani N, Sulaiman S, et al. Breast carcinoma in Pakistani females: A
morphological study of 572 breast specimens. JPMA The Journal of the Pakistan Medical Association 2000;50:174-7.
Ameli F, Rose IM, Masir N. Expression of DDR1 and DVL1 in invasive ductal and lobular breast carcinoma does not correlate with histological type, grade and hormone receptor status. Asian Pac J Cancer Prev 2015;16:2385-2390.
Albrektsen G, Heuch I, Thoresen S. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: A register-based study in Norway. BMC cancer 2010;10:226.
Anon. Rosai and Ackerman’s Surgical Pathology. JAMA 2012; 307: 201-
Acharya SC, Jha AK, Manandhar T. Clinical profile of patients presenting with breast cancer in Nepal. Kathmandu Univ Med J (KUMJ) 2012;10:3-7.
Pathak R, Jha A, Neupane P, et al. Histopathological evaluation of carcinoma of breast. Journal of Pathology of Nepal 2016;6:922.
Kakarala M, Rozek L, Cote M, et al. Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S.--a SEER analysis. BMC Cancer 2010;10:191.
Afsharfard A, Mozaffar M, Orang E, et al. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study. Asian Pac J Cancer Prev 2013;14:6905-6911.
Dai X, Xiang L, Li T, et al. Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes. J Cancer 2016;7:1281-1294.
Yang Z, Li N, Li X, et al. The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients. Onco Targets Ther 2020;13:853-863.
Nigam J, Yadav P, Sood N. A retrospective study of clinico-pathological spectrum of carcinoma breast in a West Delhi, India. South Asian journal of cancer 2014;3:179-81.
